Agilent Technologies Inc (NYSE:A) – Investment analysts at Piper Jaffray Companies issued their Q3 2019 earnings estimates for Agilent Technologies in a research note issued to investors on Tuesday, June 11th. Piper Jaffray Companies analyst W. Quirk expects that the medical research company will post earnings of $0.75 per share for the quarter. Piper Jaffray Companies has a “Overweight” rating and a $83.00 price objective on the stock. Piper Jaffray Companies also issued estimates for Agilent Technologies’ Q4 2019 earnings at $0.85 EPS, FY2019 earnings at $3.07 EPS, Q1 2020 earnings at $0.82 EPS, Q2 2020 earnings at $0.79 EPS, Q3 2020 earnings at $0.84 EPS, Q4 2020 earnings at $0.94 EPS, FY2020 earnings at $3.39 EPS and FY2021 earnings at $3.79 EPS.
Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Tuesday, May 14th. The medical research company reported $0.71 earnings per share for the quarter, missing analysts’ consensus estimates of $0.72 by ($0.01). Agilent Technologies had a return on equity of 19.71% and a net margin of 22.25%. The company had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.27 billion. During the same period in the prior year, the company posted $0.65 EPS. The firm’s revenue was up 2.7% compared to the same quarter last year.
A has been the topic of a number of other research reports. Deutsche Bank reaffirmed a “buy” rating and set a $90.00 price objective on shares of Agilent Technologies in a research report on Thursday, February 21st. Robert W. Baird reaffirmed a “buy” rating and set a $82.00 price objective (up previously from $77.00) on shares of Agilent Technologies in a research report on Wednesday, February 20th. Needham & Company LLC reaffirmed a “buy” rating and set a $88.00 price objective (up previously from $77.00) on shares of Agilent Technologies in a research report on Monday, February 25th. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $88.00 price objective on the stock in a research report on Friday, February 22nd. Finally, Barclays upped their price objective on Agilent Technologies from $80.00 to $83.00 and gave the stock an “overweight” rating in a research report on Thursday, February 21st. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $86.31.
Agilent Technologies stock opened at $70.30 on Thursday. Agilent Technologies has a twelve month low of $60.42 and a twelve month high of $82.27. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.82 and a current ratio of 3.41. The firm has a market cap of $22.15 billion, a PE ratio of 25.20, a P/E/G ratio of 1.95 and a beta of 1.40.
Hedge funds have recently modified their holdings of the business. Captrust Financial Advisors grew its holdings in shares of Agilent Technologies by 2,121.1% during the fourth quarter. Captrust Financial Advisors now owns 422 shares of the medical research company’s stock worth $29,000 after purchasing an additional 403 shares during the last quarter. Lake Point Wealth Management purchased a new position in shares of Agilent Technologies during the fourth quarter worth about $30,000. JOYN Advisors Inc. grew its holdings in shares of Agilent Technologies by 186.6% during the fourth quarter. JOYN Advisors Inc. now owns 470 shares of the medical research company’s stock worth $32,000 after purchasing an additional 306 shares during the last quarter. Destination Wealth Management grew its holdings in shares of Agilent Technologies by 100.0% during the first quarter. Destination Wealth Management now owns 400 shares of the medical research company’s stock worth $32,000 after purchasing an additional 200 shares during the last quarter. Finally, Truehand Inc purchased a new position in shares of Agilent Technologies during the fourth quarter worth about $33,000.
In other Agilent Technologies news, SVP Michael Tang sold 6,728 shares of the firm’s stock in a transaction dated Wednesday, March 27th. The stock was sold at an average price of $80.50, for a total transaction of $541,604.00. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Paul N. Clark sold 2,823 shares of the firm’s stock in a transaction dated Wednesday, March 27th. The stock was sold at an average price of $80.31, for a total value of $226,715.13. Following the transaction, the director now directly owns 88,857 shares in the company, valued at approximately $7,136,105.67. The disclosure for this sale can be found here.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 24th. Investors of record on Tuesday, July 2nd will be issued a $0.164 dividend. This represents a $0.66 annualized dividend and a yield of 0.93%. The ex-dividend date is Monday, July 1st. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.66%.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Further Reading: NASDAQ Stock Market Explained
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.